Follow
Matthew Bashton
Matthew Bashton
The Hub for Biotechnology in the Built Environment, Faculty of Health and Life Sciences, Northumbria
Verified email at northumbria.ac.uk - Homepage
Title
Cited by
Cited by
Year
SARS-CoV-2 variants, spike mutations and immune escape
WT Harvey, AM Carabelli, B Jackson, RK Gupta, EC Thomson, ...
Nature Reviews Microbiology 19 (7), 409-424, 2021
31072021
Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England
NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ...
Science 372 (6538), eabg3055, 2021
25092021
Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England
E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ...
Nature 593 (7858), 266-269, 2021
10912021
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study
T Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ...
The lancet 399 (10332), 1303-1312, 2022
10902022
Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
E Volz, V Hill, JT McCrone, A Price, D Jorgensen, O’Toole, J Southgate, ...
Cell 184 (1), 64-75. e11, 2021
10652021
SARS-CoV-2 evolution during treatment of chronic infection
SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ...
Nature 592 (7853), 277-282, 2021
9202021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study
KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ...
The Lancet Infectious Diseases 22 (1), 35-42, 2022
8092022
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial
KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ...
The Lancet 397 (10282), 1351-1362, 2021
7392021
Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies
DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ...
Nature 593 (7857), 136-141, 2021
6972021
Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data
E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ...
MedRxiv, 2020.12. 30.20249034, 2021
6032021
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ...
Cell 184 (5), 1171-1187. e20, 2021
5592021
Structure, function and evolution of multidomain proteins
C Vogel, M Bashton, ND Kerrison, C Chothia, SA Teichmann
Current opinion in structural biology 14 (2), 208-216, 2004
4802004
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7
B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ...
Cell reports 35 (13), 2021
4252021
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
BJ Willett, J Grove, OA MacLean, C Wilkie, G De Lorenzo, W Furnon, ...
Nature microbiology 7 (8), 1161-1179, 2022
4132022
Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK
L Du Plessis, JT McCrone, AE Zarebski, V Hill, C Ruis, B Gutierrez, ...
Science 371 (6530), 708-712, 2021
3722021
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study
MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ...
The Lancet Public Health 6 (5), e335-e345, 2021
3392021
SARS-CoV-2 within-host diversity and transmission
KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ...
Science 372 (6539), eabg0821, 2021
3022021
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ...
Eurosurveillance 25 (32), 2001410, 2020
2562020
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
DP Martin, S Weaver, H Tegally, JE San, SD Shank, E Wilkinson, ...
Cell 184 (20), 5189-5200. e7, 2021
2522021
Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70
SA Kemp, B Meng, IA Ferriera, R Datir, WT Harvey, G Papa, S Lytras, ...
BioRxiv, 2020.12. 14.422555, 2020
2452020
The system can't perform the operation now. Try again later.
Articles 1–20